Idorsia sells its Asia Pacific (ex-China) operations –
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – July 20, 2023 Idorsia Ltd (SIX: IDIA) today announced the sale of its operating...
Stay updated with breaking news from Mochida. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – July 20, 2023 Idorsia Ltd (SIX: IDIA) today announced the sale of its operating...
Transaction adds complementary late-stage clinical development capability with profitable and fast-growing commercial operations in JapanLean, go-to-market...
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - April 25, 2023 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first quarter of 2023. Commercial highlights QUVIVIQ
Adjuvant chemotherapy appeared associated with a significant survival benefit among patients with pancreatic ductal adenocarcinoma who underwent multiagent neoadjuvant chemotherapy and resection, according to study results.Investigators observed the survival benefit regardless patients lymph node status or resection margins.
/PRNewswire/ -- DelveInsight's Insomnia Market Insights report includes a comprehensive understanding of current treatment practices, insomnia emerging drugs,...